Conversations on CMC challenges for Calando and Cerulean at Credit Suisse conference

August 10, 2010 | Analyst Insight

We recently spoke to investors and entrepreneurs at a conference on nanotechnology hosted by Credit Suisse in San Francisco. Among the presenters were Arrowhead Research's CEO Chris Anzalone, and Cerulean Pharmaceuticals' SVP...